期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱![]() | INTERNATIONAL OPHTHALMOLOGY LetPub Score 5.2
50 ratings
Rate
Reputation 6.4 Influence 3.9 Speed 7.1 | ||||||||||||||||
期刊簡稱 | INT OPHTHALMOL | ||||||||||||||||
ISSN | 0165-5701 | ||||||||||||||||
E-ISSN | 1573-2630 | ||||||||||||||||
h-index | 40 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.springer.com/10792 | ||||||||||||||||
在線稿件提交 | https://submission.nature.com/new-submission/10792/3 | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Springer Netherlands | ||||||||||||||||
主題領域 | OPHTHALMOLOGY | ||||||||||||||||
出版國/地區 | NETHERLANDS | ||||||||||||||||
發行頻率 | 年12回刊行 | ||||||||||||||||
創刊年 | 1978 | ||||||||||||||||
每年文章數 | 291每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 16.15% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0165-5701%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: | ||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[INTERNATIONAL OPHTHALMOLOGY] 的評論 | 撰寫評論 |
作者: Adelaide Lawson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-21 19:00:15 評論於 You are in the editing allocation process, the editor has not accepted yet, you can only enter the next stage after the editor accepts it, pay more attention to the status. ![]() ![]() |
作者: 问梅殿下 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-21 15:04:15 評論於 Hello, may I ask how long it has been under review? It has been a month since submission and it is still under "editor assigned." ![]() ![]() |
作者: 东京梦森 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-21 23:16:26 評論於 The article has been accepted ![]() ![]() |
作者: 乌苏拉泽凡尼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-30 19:56:47 評論於 It has been three months and there is no progress on my end ![]() ![]() |
作者: 云居烨赫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-21 18:42:09 評論於 Do you accept dual communications? ![]() ![]() |
作者: 云居烨赫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-21 11:16:16 評論於 Do you accept dual communication? ![]() ![]() |
作者: 月河小星 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-05 08:41:54 評論於 Submitted in October 2021, currently still in editor assigned ![]() ![]() |
作者: 是你的幼白呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-03 15:14:55 評論於 Review speed: 4.0 | Submission hit rate: 75.0 Experience sharing: Submitted on August 26, 2022. Major revision on January 15, 2023. Minor revision on January 26, 2023. Accepted on April 22, 2023 ![]() ![]() |
作者: 芙蓉承颜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-27 11:56:00 評論於 Is there a follow-up? ![]() ![]() |
作者: 碧秋超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-27 18:04:19 評論於 Doesn't it not accept dual communication? ![]() ![]() |
作者: 幽花绢子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-08 09:24:39 評論於 Bro, how long has your application been under review? It's been over two months for me and there's been no progress ![]() ![]() |
作者: 东京梦森 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-01 14:39:35 評論於 The article has been accepted, right? ![]() ![]() |
作者: 东京梦森 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-08 13:47:11 評論於 I have been submitting to this magazine for three months now, and it is currently under review. I'm not sure what the situation is ![]() ![]() |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 16:18:23 評論於 Almost all submissions that meet the academic standards for publication undergo revisions by the authors before being accepted for publication. These revisions may involve changes to the wording and formatting, such as condensing the length of the article, redesigning tables, improving the quality of figures, and restricting the use of irregular abbreviations. However, revised manuscripts do not guarantee acceptance; the final decision on acceptance depends on whether the authors have adequately addressed the key content and text modifications requested by the reviewers and editors. The materials typically provided to authors for revisions include the original manuscript, reviewers' comments, and a cover letter from the editor. Upon receiving the revised manuscript, authors should carefully read the cover letter and reviewers' comments to determine if they are able and willing to implement the suggestions from the reviewers and editor. The likelihood of acceptance can be inferred from the responses of the handling editor and reviewers. It is important not to rush the revision process; authors should carefully consider and address each comment made by the reviewers, indicating specific changes made to the revised manuscript (page numbers, lines) and explaining any sections where modifications were not made ![]() ![]() |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 13:08:13 評論於 Submission completed - Format review - Initial editing - Peer review - Review completed - Final editing - Author revision ![]() ![]() |
作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 10:30:52 評論於 What is the process of refunds? ![]() ![]() |
作者: 上清雨真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 13:08:55 評論於 What is the process of peer review? ![]() ![]() |
作者: Marlon Louis 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-10-31 23:06:12 評論於 Hello, how long does it typically take for the first review? And from submission to acceptance, how long does it usually take? ![]() ![]() |
作者: 岭南乐童 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-03-04 15:36:35 評論於 This magazine has a decent submission speed, good editors, and timely email responses, making it worth recommending to everyone ![]() ![]() |
作者: 岭南乐童 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-03-03 12:18:30 評論於 This magazine has a good submission speed, and the editors are very good. They respond to emails in a timely manner, and I would recommend it to everyone ![]() ![]() |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us